Effects of serotonergic drugs in experimental brain ischemia: evidence for a protective role of serotonin in cerebral ischemia.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 8118677)

Published in Brain Res on December 10, 1993

Authors

J H Prehn1, M Welsch, C Backhauss, J Nuglisch, F Ausmeier, C Karkoutly, J Krieglstein

Author Affiliations

1: Institut für Pharmakologie und Toxikologie, Philipps-Universität, Marburg/Lahn, FRG.

Articles by these authors

Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A (1995) 2.24

[Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance]. Therapie (1999) 1.72

Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci (2003) 1.52

Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production. J Neurosci (2000) 1.29

TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. Stroke (1996) 1.29

Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor P75. Neuroscience (2002) 1.27

Transforming growth factor-beta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J Cereb Blood Flow Metab (1993) 1.20

Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J Neurosci (1998) 1.19

Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism. J Cereb Blood Flow Metab (1999) 1.16

Retinoic acid reduces apoptosis and oxidative stress by preservation of SOD protein level. Free Radic Biol Med (2001) 1.11

Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Neuroscience (2004) 1.06

PTEN: a crucial mediator of mitochondria-dependent apoptosis. Apoptosis (2006) 1.06

Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res Brain Res Rev (1999) 1.04

Influence of flupirtine on a G-protein coupled inwardly rectifying potassium current in hippocampal neurones. Br J Pharmacol (1997) 1.04

Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. Eur J Pharmacol (1999) 1.03

S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702. Brain Res (2000) 1.00

Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-kappaB. J Neurochem (2001) 0.99

Adaptive plasticity in tachykinin and tachykinin receptor expression after focal cerebral ischemia is differentially linked to gabaergic and glutamatergic cerebrocortical circuits and cerebrovenular endothelium. J Neurosci (2001) 0.98

Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Pharmacopsychiatry (2003) 0.97

Unsaturated fatty acids isolated from human lipoproteins activate protein phosphatase type 2Cbeta and induce apoptosis in endothelial cells. Atherosclerosis (2005) 0.97

NMDA-induced superoxide production and neurotoxicity in cultured rat hippocampal neurons: role of mitochondria. Eur J Neurosci (1998) 0.96

Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol (1990) 0.94

Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity. Neurosci Res (1997) 0.94

Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res (1993) 0.93

Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur J Pharmacol (1999) 0.93

Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats. Eur J Pharmacol (1999) 0.93

Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res (1996) 0.92

Neuroprotective effects of alpha-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia. Neuropharmacology (1996) 0.91

Protein phosphatases types 2Calpha and 2Cbeta in apoptosis. Biochem Soc Trans (2006) 0.90

Neuroprotective effect of 5-HT1A receptor agonist, Bay X 3702, demonstrated in vitro and in vivo. Eur J Pharmacol (1998) 0.90

Ca2+ and reactive oxygen species in staurosporine-induced neuronal apoptosis. J Neurochem (1997) 0.90

Preconditioning-induced neuroprotection is mediated by reactive oxygen species. Brain Res (2000) 0.88

Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration. Eur J Pharmacol (1995) 0.88

NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem Int (1999) 0.88

Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Eur J Pharmacol (1996) 0.87

Neuroprotective properties of 5-HT1A receptor agonists in rodent models of focal and global cerebral ischemia. Eur J Pharmacol (1991) 0.87

Isoform-specific effects of transforming growth factors-beta on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J Neurochem (1993) 0.87

Differential effects of scopolamine on neuronal survival in ischemia and glutamate neurotoxicity: relationships to the excessive vulnerability of the dorsoseptal hippocampus. J Chem Neuroanat (1997) 0.87

3-Ureidopropionate contributes to the neuropathology of 3-ureidopropionase deficiency and severe propionic aciduria: a hypothesis. J Neurosci Res (2001) 0.86

PAF antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus. J Cereb Blood Flow Metab (1990) 0.86

[Evaluation of the frequency of asthma among the adolescents attending school in the Bas-Rhin (author's transl)]. Rev Fr Mal Respir (1979) 0.85

Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol (2001) 0.85

Inhibition of glutathione depletion by retinoic acid and tocopherol protects cultured neurons from staurosporine-induced oxidative stress and apoptosis. Neurochem Int (2000) 0.84

Ciliary neurotrophic factor enhances the expression of NGF and p75 low-affinity NGF receptor in astrocytes. Brain Res (1999) 0.84

Influence of emulsified fat on chlorpromazine availability in rabbit blood. Experientia (1974) 0.84

Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur J Pharmacol (1992) 0.84

Methylmalonic acid induces excitotoxic neuronal damage in vitro. J Inherit Metab Dis (2000) 0.83

The beta2-adrenoceptor agonist clenbuterol modulates Bcl-2, Bcl-xl and Bax protein expression following transient forebrain ischemia. Neuroscience (1999) 0.83

Staurosporine-induced apoptosis in cultured chick embryonic neurons is reduced by polyethylenimine of low molecular weight used as a coating substrate. Neurosci Res (2000) 0.83

Ginseng supplementation does not enhance healthy young adults' peak aerobic exercise performance. J Am Coll Nutr (1998) 0.83

Glucose dehydrogenase of Bacillus megaterium KM. Coupling of the cytoplasmic enzyme with membrane-bound cytochromes. Biochim Biophys Acta (1969) 0.83

Effect of an extract of Ginkgo biloba on rat brain energy metabolism in hypoxia. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.83

The expression of transforming growth factor-beta1 (TGF-beta1) in hippocampal neurons: a temporary upregulated protein level after transient forebrain ischemia in the rat. Brain Res (2000) 0.83

Neuroprotective effects of TGF-beta 1. J Neural Transm Suppl (1994) 0.82

Effect of 5-hydroxytryptamine 1A receptor agonist BAY X 3702 on BCL-2 and BAX proteins level in the ipsilateral cerebral cortex of rats after transient focal ischaemia. Neuroscience (2001) 0.82

Why does atherosclerosis occur where it occurs? Atherosclerosis (2005) 0.82

Retinoic acid reduces staurosporine-induced apoptotic damage in chick embryonic neurons by suppressing reactive oxygen species production. Neurosci Lett (1998) 0.82

Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci (1986) 0.82

Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression. J Neurosci Res (2000) 0.82

[Significance of lipophilia for the neurotoxicity of penicillins]. Verh Dtsch Ges Inn Med (1974) 0.82

Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res (2001) 0.82

3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. J Inherit Metab Dis (1999) 0.81

Forearm vasoreactivity in type 1diabetic subjects. Can J Appl Physiol (2001) 0.81

TGF-beta1 inhibits caspase-3 activation and neuronal apoptosis in rat hippocampal cultures. Neurochem Int (2001) 0.81

Protective effects of 5-HT1A receptor agonists against neuronal damage demonstrated in vivo and in vitro. J Neural Transm Park Dis Dement Sect (1994) 0.81

Evidence for the involvement of Par-4 in ischemic neuron cell death. J Cereb Blood Flow Metab (2001) 0.81

Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury? Eur J Pharmacol (1995) 0.81

P-31 nuclear magnetic resonance analysis of brain: II. Effects of oxygen deprivation on isolated perfused and nonperfused rat brain. J Neurochem (1984) 0.80

Fibroblast growth factor 2 requires complex formation with ATP for neuroprotective activity. Neuroscience (2009) 0.80

Postischemic neuronal damage causes astroglial activation and increase in local cerebral glucose utilization of rat hippocampus. J Cereb Blood Flow Metab (1991) 0.80

Brain damage caused by ischemia: pathophysiological and pharmacological aspects. Dementia (1993) 0.80

Cerebral circulation, metabolism, and blood-brain barrier of rats in hypocapnic hypoxia. Am J Physiol (1987) 0.80

Beta(2)-adrenoceptor stimulation enhances latent transforming growth factor-beta-binding protein-1 and transforming growth factor-beta1 expression in rat hippocampus after transient forebrain ischemia. Neuroscience (2001) 0.80

[Bacteriolysis and bacterial cell wall]. Pathol Microbiol (Basel) (1966) 0.80

Effects of vinpocetine on local cerebral blood flow and glucose utilization seven days after forebrain ischemia in the rat. Pharmacology (1990) 0.80

A mouse model of focal cerebral ischemia for screening neuroprotective drug effects. J Pharmacol Toxicol Methods (1992) 0.80

Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase deficiency. Pediatr Res (2000) 0.80

[Decomposition of 2-deoxyhexoses during metabolism, V. Incorporation of 2-deoxy-D-glucose into glucotriose by Streptococcus faecalis]. Hoppe Seylers Z Physiol Chem (1967) 0.80

[Cost of hospitalizations for adverse drug effects]. Therapie (2000) 0.79

Protective effect of vinpocetine against brain damage caused by ischemia. Jpn J Pharmacol (1991) 0.79

Mechanisms of drug actions against neuronal damage caused by ischemia--an overview. Prog Neuropsychopharmacol Biol Psychiatry (1993) 0.79

Quantitative analysis of the electrocorticogram after forebrain ischemia in the rat. Pharmacology (1995) 0.79

Stimulation of 5-HT1A receptor inhibits apoptosis induced by serum deprivation in cultured neurons from chick embryo. Brain Res (1997) 0.79

Morphology of tissue damage due to experimental cerebral ischemia in rats. Exp Pathol (1988) 0.79

Conditioning of apomorphine effects: simultaneous analysis of the alterations in cortical electroencephalogram and behaviour. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.79

Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharmacol Res Commun (1988) 0.79

Opposing effects of transforming growth factor-beta 1 on glutamate neurotoxicity. Neuroscience (1994) 0.79

Apomorphine-induced alterations in cortical EEG activity of rats. Involvement of D-1 and D-2 dopamine receptors. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.79

Dihydrolipoate reduces neuronal injury after cerebral ischemia. J Cereb Blood Flow Metab (1992) 0.79

The 5-HT1A receptor agonist Bay x 3702 inhibits apoptosis induced by serum deprivation in cultured neurons. Eur J Pharmacol (1999) 0.79

Calcium entry blockers protect brain energy metabolism against ischemic damage. Adv Exp Med Biol (1986) 0.79

Prolonged pretreatment with alpha-lipoic acid protects cultured neurons against hypoxic, glutamate-, or iron-induced injury. J Cereb Blood Flow Metab (1995) 0.79